Gallamini A, Viviani S, Rapezzi D, Patti C, et al. Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial). Br J Haematol 2026 Aug 26. doi: 10.1111/bjh.70763.
PMID: 42644287